Angelica sinensis polysaccharide combined with cisplatin reverses cisplatin resistance of ovarian cancer by inducing ferroptosis via regulating GPX4.
Angelica sinensis polysaccharide (ASP) reverses cisplatin resistance in ovarian cancer cells by suppressing GPX4 expression. ASP in combination with cisplatin shows promise in overcoming drug resistance.
- Guo W et al (2024).
- Biomed Pharmacother.
- PubMed:
- 38703506